Year To Quarter End Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7732093

Concept 2017-01-01 to
2017-09-30
2016-01-01 to
2016-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-508,324,000 JPY
-178,334,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
18,000 JPY
-114,012,000 JPY
Deferred gains or losses on hedges
JPY
1,696,000 JPY
Foreign currency translation adjustment
-1,238,000 JPY
-11,425,000 JPY
Other comprehensive income
-1,220,000 JPY
-123,741,000 JPY
Comprehensive income
-509,545,000 JPY
-302,076,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-509,545,000 JPY
-302,076,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.